Miguel Ángel Salazar-Lezama

Classifying new anti-tuberculosis drugs: rationale and future perspectives

Simon Tiberi, Anna Scardigli, Rosella Centis et al. · International Journal of Infectious Diseases · 2016 · 110 citations · Full text

The Tim3–Galectin 9 Pathway Induces Antibacterial Activity in Human Macrophages Infected with <i>Mycobacterium tuberculosis</i>

Isabel Sada‐Ovalle, Leslie Chávez‐Galán, Luis Torre‐Bouscoulet et al. · The Journal of Immunology · 2012 · 91 citations

Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection

Puthayalai Treerat, Olivier D. Prince, Alfredo Cruz‐Lagunas et al. · Mucosal Immunology · 2017 · 88 citations · Full text

Inflammation, Pulmonary Tuberculosis, Tuberculosis Prevention +7

Interleukin-17 limits hypoxia-inducible factor 1α and development of hypoxic granulomas during tuberculosis

Racquel Domingo-Gonzalez, Shibali Das, Kristin Griffiths et al. · JCI Insight · 2017 · 57 citations · Full text

Microbial Pathogens, Immunology, Immune Regulation +19

[National consensus of diagnosis and treatment of non-small cell lung cancer].

Óscar Arrieta, Enrique Guzmán-de Alba, Luis Felipe Alba-López et al. · PubMed · 2013 · 46 citations

Translational Medicine, Surgical Oncology, Lung Cancer Treatment +14